Deep Tech Startups

Lydus Medical develops surgical devices for anastomosis procedures in microsurgery, combining clinical insight with engineering to make these operations faster and more reliable. The company was founded within Sanara Ventures based on a clinical need identified in the microsurgery operating room.

1 investor

LymphaTouch is a Finnish health technology company that manufactures a medical device combining negative pressure and mechanical vibration for manual therapy applications including edema management, soft tissue mobilization, scar therapy, and pain management.

1 investor

Lync Bio develops fourth-generation SMART ADC (antibody-drug conjugate) technology for oncology, leveraging proprietary dual-target conjugate design and payload engineering to improve tumor coverage, cellular response, and manufacturability.

1 investor

LynxBio (Lynx Biosciences) is a biotech company developing immuno-oncology and immunology therapies using a proprietary patient-based ex vivo disease biology platform combined with a multiomics approach for drug discovery. It partners with biopharmaceutical and technology companies to identify therapeutic candidates while advancing its own internal pipeline.

1 investor

Lyrasense provides a cloud-based geospatial intelligence platform that integrates satellite data analysis, AI-powered processing, and visualization to reduce the time from raw data to actionable insights. The platform serves organizations in energy, mining, telecommunications, and other industries that need to process multi-source Earth observation data without building fragmented tool chains.

1 investor

Lysk is a European defense technology startup building modern software designed for hostile environments, bringing cloud infrastructure practices in security and networking to European armies. It serves military and defense organizations across Europe.

1 investor

Lyterian Therapeutics develops pharmaceutical treatments by leveraging protein homeostatic mechanisms to target genetically-validated disease drivers. The company focuses on transformative medicines for patients across multiple disease areas.

1 investor

MXR develops Marso Measure, a photogrammetry-based software for capturing high-fidelity 3D assets and measuring physically based rendering (PBR) material maps such as albedo, diffuse, roughness, specular, metallic, and normal. The tool reconstructs geometry and processes measured PBR maps locally using any co-located light system.

1 investor

M20 Genomics develops single-cell and spatial transcriptome sequencing technologies for life science research, drug discovery, and disease diagnosis applications. The company offers proprietary VITA and NATA product lines based on its M20 Seq and M20 Spatial technologies.

1 investor

M31 Capital is an investment firm that uses systematic research across physics, history, macroeconomics, technology, and geopolitics to identify emerging technology paradigm shifts. The firm advises private investors, institutions, and sovereign wealth funds on long-term technology trends and investment positioning.

1 investor

MA-TEK manufactures high-technology products and components, offering services in packaging, testing, and systems integration with advanced analytical detection techniques. The company supports research and development in innovative components and materials, primarily serving academic and industrial partners in Taiwan.

1 investor

Maaind builds emotion- and physiological-state detection technology that fuses voice, vision, and cardiac signals to read a person's emotion, stress, focus, fatigue, drowsiness, and engagement in real time. Its inference engine runs in the cloud or on-device offline, serving automotive driver/occupant monitoring, voice AI agents, health and wellbeing, defence operator monitoring, and insurance.

1 investor

MabGenesis is a Japanese startup biopharmaceutical company that commercializes decades of academic antibody research to develop first-in-class and best-in-class therapeutic monoclonal antibody drugs for both human and animal use. Using its MOURA antibody library and IMPACT high-efficiency monoclonal antibody isolation technology, it targets high-unmet-need areas such as cancer and zoonotic diseases, and has built dog and cat antibody libraries for the veterinary drug market.

1 investor

MNE is an oil and gas exploration company that develops two exploration permits in Western Australia's Northern Perth Basin. The company focuses on prospecting and development activities in onshore regions of Western Australia.

1 investor

Mach Industries develops advanced defense systems including turbojet-powered vertical takeoff attack drones, glide munitions, high-altitude pseudo-satellites, and kinetic interceptors, along with propulsion and explosives testing capabilities. It serves defense and military applications with low-cost, mass-deployable precision strike and counter-drone technologies.

1 investor

Mach42 develops AI tools for high-performance computing tasks, including analog circuit simulation and test plan development for semiconductors as well as real-time fusion control mechanisms. Its products target chip design and verification workflows, such as accelerated design exploration for silicon verification.

1 investor

MACOM designs and manufactures semiconductor products across silicon, gallium arsenide, and indium phosphide technologies, serving customers who need specialized semiconductor solutions. The company operates fabrication facilities, design centers, and foundry services globally.

1 investor

Maculaser develops a temperature-controlled retinal laser therapy to treat age-related macular degeneration, diabetic macular edema, and other retinal disorders by activating natural healing responses in eye cells. The company targets patients and healthcare providers globally for disease prevention and non-invasive retinal care.

1 investor

MAG-LAB provides NMR spectroscopy services combined with selective protein isotope labeling techniques to analyze protein-ligand interactions at atomic resolution for drug discovery. It supports pharmaceutical and medicinal chemistry teams in hit finding, hit-to-lead optimization, binding site mapping, and characterizing challenging targets including intrinsically disordered proteins.

1 investor

Magdrive develops high-thrust electric plasma propulsion systems for satellites and spacecraft, aimed at operators running missions in low Earth orbit and deep space. The company builds a family of storable electric thrusters for the space industry.

1 investor

Maglut develops rare earth element purification technology, focusing on precision purification processes for domestic U.S. rare earth production.

1 investor

Magma Global manufactures m-pipe, a composite subsea pipeline system made from PEEK and carbon fibre for oil and gas exploration and production. The product replaces traditional steel and flexible pipes in deep-water applications, delivering cost savings up to 65% while reducing corrosion, temperature, and pressure challenges.

1 investor

Magment develops magnetizable concrete and asphalt made with recycled ferrite materials for contactless wireless charging and power transmission infrastructure. Its MagPower and MagCharge products target applications such as road electrification, warehouses, data centers, and micromobility.

1 investor

Magnefy develops hybrid magnetic sensing and signal-processing hardware combined with AI/ML for monitoring critical infrastructure in harsh, real-world environments. The company applies sensor, connectivity, and data-infrastructure technologies to energy and industrial applications.

1 investor